ClinicalTrials.Veeva

Menu

Improvement of Cerebrovascular Autoregulation in Patients With Septic Shock Due to Cytokine Elimination (SepsAR3)

J

Johannes Gutenberg University (JGU)

Status

Unknown

Conditions

Septic Shock

Treatments

Device: Cytokine absorption

Study type

Interventional

Funder types

Other

Identifiers

NCT04259567
V1.0_2019_06_28

Details and patient eligibility

About

The trial investigates the effect of cytokine elimination in patients with septic schock and acute renal failure with need for renal replacement therapy on the integrity of cerebrovascular autoregulation. Patients with inclusion criteria were randomly assign in either use of CytoSorb filter integrated in renal replacement therapy versus non additional filter an renal replacement therapy alone. Cerebrovascular autoregulation will be measured with transcranial Doppler ultrasound and correlation with arterial blood pressure.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • septic shock
  • acute renal failure with need for renal replacement therapy

Exclusion criteria

  • pregnancy
  • nursing
  • impossibility to do transcranial Doppler ultrasound

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

150 participants in 2 patient groups

Filter
Active Comparator group
Description:
Patients with CytoSorb absorber
Treatment:
Device: Cytokine absorption
Control
No Intervention group
Description:
Patients without CytoSorb absorber

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems